Expanding footprint Belmar Pharma Solutions has recently opened a new facility in Florida and announced plans to create 150 jobs over the next three years, indicating growth momentum and potential new market access opportunities in the southeastern United States.

Women’s Health leadership With a long-standing focus on women’s health and a dedicated Women’s Health team, Belmar presents a strong alignment for partnerships or co-development in hormone therapies and personalized compounding for menopause and related conditions.

Integrated capabilities The company operates multiple Compounding Centers of Excellence licensed in all 50 states and has completed strategic acquisitions, suggesting potential for cross-sell of 503A/503B services and expanded contractual collaborations.

Strategic partnerships Recent pharmacy partner expansions and acquisitions (including Women’s International Pharmacy) indicate a willingness to form alliance networks, creating opportunities for channel partnerships, sourcing arrangements, or joint ventures.

Scale and reliability With revenues in the multi‑hundred million range, a broad tech stack and enterprise hosting, Belmar demonstrates scale and operational reliability that can support large healthcare systems, hospital networks, and national provider organizations seeking trusted compounding partners.